Maryland?s biotech and bioscience industry is poised to grow stronger and become an even more important sector of the state?s economy, according to two recent reports.

The industry could top $4 billion in future revenue ? and that?s just for the publicly traded biotech firms in Maryland, said Rene Salas, a partner with the life sciences division of Ernst & Young.